Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.27% is 71% below its 5-year average of 14.86%, near the low end of its 5-year range (4.27%–57.15%).
26.82% below its 12-month average of 5.83%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
4.27%
RETURN ON ASSETS (ROA) AVG TTM
5.83%
RETURN ON ASSETS (ROA) AVG 3Y
5.87%
RETURN ON ASSETS (ROA) AVG 5Y
14.86%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-26.82%
CURRENT VS 3Y AVG
-27.20%
CURRENT VS 5Y AVG
-71.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.94%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-13.56%
vs the sector median at left
GE HealthCare Technologies Inc.
Market Cap
$33.04B
Return on Assets (ROA)
4.27%
TTM Avg
5.83%
3Y Avg
5.87%
5Y Avg
14.86%
Market Cap
$32.86B
Return on Assets (ROA)
-6.14%
TTM Avg
-2.29%
3Y Avg
0.04%
5Y Avg
0.75%
Market Cap
$32.61B
Return on Assets (ROA)
16.99%
TTM Avg
17.06%
3Y Avg
15.57%
5Y Avg
14.60%
Market Cap
$34.15B
Return on Assets (ROA)
15.49%
TTM Avg
11.04%
3Y Avg
9.26%
5Y Avg
8.83%
Market Cap
$31.13B
Return on Assets (ROA)
2.60%
TTM Avg
5.11%
3Y Avg
6.74%
5Y Avg
8.29%
Market Cap
$31.08B
Return on Assets (ROA)
0.67%
TTM Avg
13.34%
3Y Avg
15.53%
5Y Avg
17.15%
Market Cap
$31.02B
Return on Assets (ROA)
17.35%
TTM Avg
17.37%
3Y Avg
16.33%
5Y Avg
15.33%
Market Cap
$30.34B
Return on Assets (ROA)
14.54%
TTM Avg
-0.12%
3Y Avg
-10.91%
5Y Avg
-15.37%
Market Cap
$30.07B
Return on Assets (ROA)
1.76%
TTM Avg
3.17%
3Y Avg
1.75%
5Y Avg
1.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (GEHC) | $33.04B | 4.27% | 5.83% | 5.87% | 14.86% |
| Centene Corp. (CNC)vs › | $32.86B | -6.14% | -2.29% | 0.04% | 0.75% |
| ResMed Inc. (RMD)vs › | $32.61B | 16.99% | 17.06% | 15.57% | 14.60% |
| DexCom, Inc. (DXCM)vs › | $34.15B | 15.49% | 11.04% | 9.26% | 8.83% |
| Biogen Inc. (BIIB)vs › | $31.13B | 2.60% | 5.11% | 6.74% | 8.29% |
| Waters Corporation (WAT)vs › | $31.08B | 0.67% | 13.34% | 15.53% | 17.15% |
| Zoetis Inc. (ZTS)vs › | $31.02B | 17.35% | 17.37% | 16.33% | 15.33% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $30.34B | 14.54% | -0.12% | -10.91% | -15.37% |
| Medline Inc. (MDLN)vs › | $30.07B | 1.76% | 3.17% | 1.75% | 1.75% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.73B | 24.67% | 25.02% | 24.63% | 23.85% |
ROA
4.3%
ROE
14.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 5.65% |
| 2024-12-31 | 6.02% |
| 2023-12-31 | 4.83% |
| 2022-12-31 | 6.96% |
| 2021-12-31 | 8.54% |
| 2020-12-31 | 57.15% |
| 2019-12-31 | 0.00% |
